Chiara Signori graduated in Pharmaceutical Biotechnology from Università degli Studi of Milan in 2021. For her thesis she worked at Mario Negri Research Institute, in the department of Clinical Cardiovascular Research. She then moved to Basel, Switzerland, where she worked at Roche on analytical methods for gene therapy products.

In November 2022 she started her PhD at Humanitas University and she is working in the Carlo-Stella Group of Humanitas Research Hospital in Lymphoma translational research.